Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Eric Humke
Introduction
Eric Humke is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and patent.
Latest Patents
Eric Humke holds a patent for the "Use of human epididymis protein 4 (HE4) for assessing responsiveness of MUC 16-positive cancer treatment." This invention relates to methods and kits that assess the responsiveness of cancers to MUC16 antagonists by monitoring HE4 expression. The methods include measuring the level of HE4 expression in a sample from a subject and comparing it with previous samples. This innovative approach may lead to more effective cancer treatments.
Career Highlights
Eric Humke is associated with Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Genentech has allowed him to contribute to groundbreaking research in cancer therapies.
Collaborations
Throughout his career, Eric has collaborated with talented individuals such as Mark Lackner and Daniel Maslyar. These collaborations have further enhanced his research and development efforts in the field of oncology.
Conclusion
Eric Humke's contributions to cancer treatment through his patent and work at Genentech highlight his role as an innovative inventor. His research may pave the way for advancements in cancer therapies, ultimately benefiting patients worldwide.